Posted in | News

Radiation Shield Technologies to Discuss How to Prepare U.S. for Possible Radiological Threats

Ronald F. DeMeo, M.D., MBA, president and chief executive officer of Radiation Shield Technologies (RST), will join top homeland security and policy experts in a panel discussion titled "Federal and Local Resources Needed to Meet the Challenges Posed by Radiological Threats," which takes place during the 2009 Radiological Threat Summit. The discussion is scheduled for 11 a.m. to 12 p.m. Wed., Feb. 25, at the National Press Club's "Holeman Lounge," located at 529 14 St NW, Washington, D.C., 20045.

The summit, sponsored by the Radiological Threat Awareness Coalition (R-TAC), brings together leaders, policymakers, regulators, first responders and other stakeholders to engage in a robust dialogue about how to prevent, prepare and respond to radiological threats facing the U.S. This year's event includes a keynote presentation to unveil a new scenario-driven preparedness primer for responders during and after a radiological incident.

Dr. DeMeo, a leading pioneer in the field of personal-protection systems, was invited to discuss ways to support federal- and state-level efforts to better prepare the U.S. The panel, moderated by Jim Pinkerton, R-TAC's chairman, also includes: Dr. Jeffrey W. Runge, former chief medical officer of the U.S. Department of Homeland Security; Dr. Carol Marcus, a member of FEMA's National Medical Response Team; Lawrence Korb, with the Center for American Progress; and Alexander Heyl, with Heyltex Corporation.

"Traditionally, our Federal Government has primarily focused on studying and preparing for the possibility of nuclear attacks to the U.S. and, for this reason, one of the main goals of this year's Radiological Threat Summit is to elevate awareness of the need to allocate more resources toward better preparing the U.S. for the threat of dirty bombs, which are conventional explosives packed to disperse radioactive materials," said Dr. DeMeo, the world-renowned surgeon and entrepreneur who invented the patented Demron, the world's first and only protective material for all types of chemical, biological, radiological and nuclear incidents. "As the only company that develops advanced personal-protection technologies that are scientifically proven to counter these types of incidents, Radiation Shield Technologies was asked to participate in the panel discussion. We are honored to engage in this dialogue, and we consider it our mission to help raise awareness and identify solutions for the significant challenges posed by radiological threats."

Demron, which has many U.S. and international patents, consists of an advanced radiopaque nanopolymeric compound fused between layers of fabric and manufactured into lightweight nuclear-radiation blocking garments including full-body suits, vests, blankets and medical X-ray vests and aprons. Demron's nanotechnology surpasses current NBC suits, which provide limited radioactive protection. Demron has proved to block gamma rays, X-rays and nuclear emissions in studies by the Lawrence Livermore National Laboratory, part of the National Nuclear Security Administration within the U.S. Department of Energy, and the Georgia Institute of Technology and the Columbia University College of Physicians and Surgeons. According to the The Spine Journal, 6 (2006) 577-582, Demron is the most lightweight material available for X-ray shielding.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.